# Supernus Pharmaceuticals, Inc.: Form 8-K/A, filed Oct 16, 2025

- Company: [Supernus Pharmaceuticals, Inc.](/companies/supn.md) (CIK 1356576)
- Form: 8-K/A
- Filed: 2025-10-16
- Accepted by EDGAR: Oct 16, 2025, 16:11 ET
- Period: 2025-07-31
- Accession: 0001356576-25-000062
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1356576/000135657625000062/supn-20250731.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1356576/000135657625000062/

## Items reported

- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1356576/000135657625000062/supn-20250731.htm

Filed Oct 16, 2025.
Source: SEC EDGAR, the filing index for accession 0001356576-25-000062. Last ingested by Listed: Nov 4, 2026, 18:21 ET. No prices; not investment advice.